MASTROCOLA, Raffaella
 Distribuzione geografica
Continente #
NA - Nord America 12.859
EU - Europa 6.555
AS - Asia 6.456
SA - Sud America 823
Continente sconosciuto - Info sul continente non disponibili 695
AF - Africa 139
OC - Oceania 49
Totale 27.576
Nazione #
US - Stati Uniti d'America 12.494
CN - Cina 2.249
SG - Singapore 2.198
IT - Italia 2.047
SE - Svezia 662
BR - Brasile 638
VN - Vietnam 631
DK - Danimarca 551
IE - Irlanda 549
DE - Germania 524
FR - Francia 488
FI - Finlandia 375
GB - Regno Unito 339
UA - Ucraina 282
JP - Giappone 241
KR - Corea 221
CA - Canada 194
IN - India 157
HK - Hong Kong 154
PL - Polonia 150
BD - Bangladesh 135
AT - Austria 127
MX - Messico 90
ES - Italia 87
ID - Indonesia 87
TR - Turchia 82
BE - Belgio 76
AR - Argentina 71
NL - Olanda 68
IQ - Iraq 54
RU - Federazione Russa 50
TW - Taiwan 46
AU - Australia 44
ZA - Sudafrica 34
EG - Egitto 28
RO - Romania 28
JM - Giamaica 27
PH - Filippine 27
CL - Cile 24
VE - Venezuela 24
GR - Grecia 22
MA - Marocco 22
SA - Arabia Saudita 22
CH - Svizzera 20
CZ - Repubblica Ceca 20
CO - Colombia 19
PK - Pakistan 19
NO - Norvegia 17
EC - Ecuador 16
TH - Thailandia 16
KE - Kenya 15
EU - Europa 14
PE - Perù 14
SN - Senegal 14
CR - Costa Rica 13
IL - Israele 13
IR - Iran 13
UZ - Uzbekistan 13
HU - Ungheria 12
JO - Giordania 11
LT - Lituania 11
TN - Tunisia 10
AE - Emirati Arabi Uniti 9
BY - Bielorussia 9
KZ - Kazakistan 9
MY - Malesia 7
PT - Portogallo 7
PY - Paraguay 7
AL - Albania 6
NP - Nepal 6
UY - Uruguay 6
BG - Bulgaria 5
GT - Guatemala 5
HN - Honduras 5
LB - Libano 5
MO - Macao, regione amministrativa speciale della Cina 5
PR - Porto Rico 5
AZ - Azerbaigian 4
BO - Bolivia 4
SV - El Salvador 4
TT - Trinidad e Tobago 4
BA - Bosnia-Erzegovina 3
BS - Bahamas 3
CY - Cipro 3
DZ - Algeria 3
HR - Croazia 3
NZ - Nuova Zelanda 3
OM - Oman 3
PA - Panama 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
A1 - Anonimo 2
AG - Antigua e Barbuda 2
AM - Armenia 2
BH - Bahrain 2
BZ - Belize 2
DO - Repubblica Dominicana 2
GE - Georgia 2
KH - Cambogia 2
KW - Kuwait 2
Totale 26.859
Città #
Ann Arbor 1.993
Singapore 1.187
Chandler 944
Beijing 840
Ashburn 814
San Jose 791
Dublin 546
Fairfield 473
Torino 473
Santa Clara 455
Houston 442
Wilmington 336
Woodbridge 247
Dearborn 229
Turin 223
Jacksonville 216
Seattle 206
Nyköping 197
Villeurbanne 195
Milan 186
Los Angeles 175
Cambridge 168
Medford 158
Ho Chi Minh City 157
Princeton 146
Columbus 139
Helsinki 138
Redwood City 138
The Dalles 138
Warsaw 137
Pisa 136
Rome 130
Lauterbourg 128
Hanoi 114
Shanghai 113
New York 111
Tokyo 111
Dong Ket 106
Guangzhou 105
Hong Kong 103
Frankfurt am Main 97
Dallas 93
Vienna 92
Buffalo 83
Munich 82
Nanjing 81
Nuremberg 77
Jakarta 74
Council Bluffs 71
Boston 67
Boardman 64
São Paulo 60
Seoul 58
Hefei 55
Brussels 54
Fremont 50
Toronto 49
Phoenix 47
Orem 44
Zhengzhou 42
Washington 38
London 37
Atlanta 36
Düsseldorf 36
Chicago 35
Wuhan 35
Xian 35
Chengdu 32
Montreal 32
San Diego 31
Memphis 30
Chennai 28
Taipei 28
Lappeenranta 27
Naples 27
Shenyang 26
Verona 26
Haiphong 25
Ottawa 25
Rio de Janeiro 25
Brooklyn 24
Chongqing 24
Kunming 24
Norwalk 24
Baghdad 23
Changsha 23
Philadelphia 23
Turku 22
Ankara 21
Hangzhou 21
Hebei 21
Manchester 21
Stockholm 21
Da Nang 20
Denver 20
Kingston 20
Silver Spring 20
Jinan 19
Mexico City 19
Redondo Beach 19
Totale 16.027
Nome #
Metaflammation: tissue-specific alterations of the NLRP3 inflammasome platform 1.392
Stable Oxidative Cytosine Modifications Accumulate in Cardiac Mesenchymal Cells from Type2 Diabetes Patients: Rescue by alpha Ketoglutarate and TET-TDG Functional Reactivation 588
Combining doxorubicin-nanobubbles and shockwaves for Anaplastic thyroid cancer treatment: Preclinical study in a xenograft mouse model 541
Fructose liquid and solid formulations differently affect gut integrity, microbiota composition and related liver toxicity: a comparative in vivo study 479
Pharmacological inhibition of NLRP3 inflammasome attenuates myocardial ischemia/reperfusion injury by activation of RISK and mitochondrial pathways 416
Anti-Glycation Properties of Zinc-Enriched Arthrospira platensis (Spirulina) Contribute to Prevention of Metaflammation in a Diet-Induced Obese Mouse Model 400
Maladaptive Modulations of NLRP3 Inflammasome and Cardioprotective Pathways Are Involved in Diet-Induced Exacerbation of Myocardial Ischemia/Reperfusion Injury in Mice 393
A non-erythropoietic peptide derivative of erythropoietin decreases susceptibility to diet-induced insulin resistance in mice 392
Combined untargeted and targeted fingerprinting by comprehensive two-dimensional gas chromatography: revealing fructose-induced changes in mice urinary metabolic signatures 392
Reversal of the deleterious effects of chronic dietary HFCS-55 intake by PPAR- agonism correlates with impaired NLRP3 inflammasome activation 386
Accumulation of Advanced Glycation End-Products and Activation of the SCAP/SREBP Lipogenetic Pathway Occur in Diet-Induced Obese Mouse Skeletal Muscle. 374
Advanced glycation end-products promote hepatosteatosis by interfering with SCAP-SREBP pathway in fructose drinking mice 357
Alpha-2A Adrenoceptor Agonist Guanfacine Restores Diuretic Efficiency in Experimental Cirrhotic Ascites: Comparison with Clonidine 356
Dysregulation of SREBP2 induces BACE1 expression. 354
Is NLRP3 inflammasome a new pharmacological target in myocardial ischemia/reperfusion injury? 347
Hippocampal heat shock protein 25 expression in streptozotocin-induced diabetic mice. 345
Targeting the NLRP3 inflammasome to reduce diet-induced metabolic abnormalities in mice 320
High Sugar Intake and Development of Skeletal Muscle Insulin Resistance and Inflammation in Mice: A Protective Role for PPAR- δ Agonism. 318
Dietary sugars and endogenous formation of advanced glycation endproducts: Emerging mechanisms of disease 315
Role of Chymase in the Development of Liver Cirrhosis and Its Complications: Experimental and Human Data 311
Exacerbation of myocardial ischemia/reperfusion injury induced by high-fat-high-fructose (HFHF) diet: Role of NLRP3 inflammasome 303
Altered hepatic sphingolipid metabolism in insulin resistant mice: Role of advanced glycation endproducts 303
Variability in myosteatosis and insulin resistance induced by high-fat diet in mouse skeletal muscles. 298
Fructose-derived advanced glycation end-products induce a negative crosstalk between lipogenesis and muscle reprogramming in mice through SREBP-1c 291
Chronic administration of saturated fats and fructose differently affect SREBP activity resulting in different modulation of Nrf2 and Nlrp3 inflammasome pathways in mice liver 289
SALIVAGE – EU JPI Project The “form” makes the difference: comprehensive two‐dimensional gas chromatography as highly informative fingerprinting tool to study the impact of fructose formulation on mice’s microbiota and its volatile metabolome signatures 280
High-fructose intake as risk factor for neurodegeneration: Key role for carboxy methyllysine accumulation in mice hippocampal neurons 271
Cannabinoid receptor 1 blockade ameliorates albuminuria in experimental diabetic nephropathy 270
A LIPIDOMIC STUDY OF HIGH-FAT DIET TREATED MICE. 264
Advanced Glycation End Products Inhibition Restores Sphingolipid Rheostat in Mice Liver and Prevents Diet-Induced Insulin Resistance 264
Effects of exogenous dietary advanced glycation end products on the cross-talk mechanisms linking microbiota to metabolic inflammation 258
Baricitinib counteracts metaflammation, thus protecting against diet-induced metabolic abnormalities in mice 253
KRIT1 Deficiency Promotes Aortic Endothelial Dysfunction 252
Fructose-derived advanced glycation end-products drive lipogenesis and skeletal muscle reprogramming via SREBP-1c dysregulation in mice 250
Effects of Vitamin D on insulin resistance and myosteatosis in diet-induced obese mice 247
Effects of chronic sugar consumption on lipid accumulation and autophagy in the skeletal muscle 242
Pyridoxamine prevents diet-induced insulin resistance through the regulation of ceramide/sphingosine/sphingosine-1-phosphate equilibrium in mice liver 239
Advanced glycation end products (AGEs) as pathology biomarkers: microwave assisted synthesis and biological quantitative analysis by LC-FTMS 238
A nonerythropoietic peptide analog of erythropoietin decreases susceptibility to diet-induced insulin resistance 237
Oxidative stress and inflammatory response evoked by transient cerebral ischemia/reperfusion: effects of the PPAR-alpha agonist WY14643 237
Identification of Annexina1 as an endogenous regulator of RhoA, and its role in the pathophysiology and experimental therapy of type-2 diabetes 236
Obestatin induced recovery of myocardial dysfunction in type 1 diabetic rats: underlying mechanisms. 232
Fructose-Derived Advanced Glycation End-Products Evoke Skeletal Muscle Damage in Mice by Multiple Interference with SCAP-SREBP Pathway 230
Effects of CB1 Blockade In Experimental Diabetic Nephropathy 210
Calcium receptors located in fibrotic septa: a new target to reduce portal pressure in liver cirrhosis 210
Oxidative stress and kidney dysfunction due to ischemia/reperfusion in rat: attenuation by dehydroepiandrosterone. 210
Toxicological impact of high fructose intake on gut microbiota and liver/intestine integrity: Any differences between solid and liquid formulations? 208
Il blocco del recettore CB1 nella nefropatia diabetica sperimentale 207
Advanced glycation end products and chronic inflammation in adult survivors of childhood leukemia treated with hematopoietic stem cell transplantation 206
Protective Effects of Pyridoxamine Supplementation in the Early Stages of Diet-Induced Kidney Dysfunction 203
Pharmacological Inhibition of FAK-Pyk2 Pathway Protects Against Organ Damage and Prolongs the Survival of Septic Mice 197
AGEs and neurodegeneration: the Nrf2/glyoxalase-1 interaction. 195
AGEs induce alterations of sphingolipids metabolism in the liver of genetically- and diet-induced diabetic mice 191
Dietary advanced glycation endproducts in the mechanisms linking proteins glycosylation pattern, microbiota, and metabolic inflammation 188
Dose-dependecy of clonidine's effects in ascitic cirrhotic rats: Comparison with α1-adrenergic agonist midodrine. 185
Cardiac Epi-Metabolic Signature Revealed by Integrated Omics Approach in Diabetic Patients: Rescue by Active DNA Demethylation via TET-TDG Complex Reactivation 185
Inhibition of chymase-dependent production of kidney angiotensin II improves renal sodium handling and prevents ascites in experimental liver cirrhosis 184
Deletion of RAGE fails to prevent hepatosteatosis in obese mice due to impairment of other AGEs receptors and detoxifying systems 182
ICOS-Fc as innovative immunomodulatory approach to counteract inflammation and organ injury in sepsis 180
Heat Shock Proteins in Vascular Diabetic Complications: Review and Future Perspective 179
Baricitinib counteracts metaflammation protecting against diet-induced metabolic abnormalities in mice 179
Dynamics of sodium retention in preascitic cirrhotic rats assessed through parathyroid hormone injection. 178
MicroRNA and microvascular complications of diabetes 178
AGEs up-regulates BACE1 through their interaction with RAGE and NFkB activation. 177
Effects of empagliflozin in a murine model of diet-induced insulin resistance: A role for NLRP3 inflammasome inhibition? 177
KRIT1/CCM1 Loss-of-function Mutations Impair Anti-glycative and Anti-oxidant Systems Worsening High Fructose Diet-induced Hepatic Dismetabolism 176
Inflammatory signaling and insulin resistance caused by sugar intake: modulation by PPAR-δ agonism 167
Pathogenesis of Solute-Free Water Retention in Experimental Ascitic Cirrhosis: Is Vasopressin the Only Culprit? 167
Ischemic preconditioning attenuates the oxidant-dependent mechanisms of reperfusion cell damage and death in rat liver. 165
Heterozygous Loss of KRIT1 in Mice Affects Metabolic Functions of the Liver, Promoting Hepatic Oxidative and Glycative Stress 163
The AGEs inhibitor pyridoxamine prevents kidney injury and dysfunction in mice fed high-fat high-fructose diet 163
Empagliflozin Protects against Diet-Induced NLRP-3 Inflammasome Activation and Lipid Accumulation 162
Considerable aquaretic effects in experimental ascitic cirrhosis achieved through blunting of adrenergic function with α2A adrenergic receptor agonists 158
Identification of risk factors and biomarkers of diagnostic and prognostic value associated with clinical progression and severity of cerebral cavernous malformations 156
Telomere lenght measurement in the clinically oriented research setting: a comparison between Southern blot (SB), real time quantitative PCR (RQ-PCR) and FLOW-FISH (FF) 149
KRIT1/CCM1 loss-of-function impairs advanced glycation endproducts receptors and detoxification and worsens fructose diet-induced hepatic dysmetabolism 148
Advanced Glycation End-Products Promote Lipogenesis in Liver of Fructose-Drinking Mice 147
KRIT1/CCM1 loss-of-function affects sphingolipid metabolism inducing hepatosteatosis and predisposing to liver fibrosis and insulin-resistance 144
Inhibition of AGEs by pyridoxamine prevents diet-induced systemic inflammation and skeletal muscle insulin resistance by restoring SphK/S1P3/RhoA signalling 142
Anti-inflammatory and anti-glycative properties of zinc-enriched spirulina in diet-induced obese/diabetic mice 141
Cannabinoid Receptors in Diabetic Kidney Disease 139
Modulations of the calcineurin/NF-AT pathway in skeletal muscle atrophy 136
Dehydroepiandrosterone in diabetic rats: protection against NFkB activation. 136
Reduced Susceptibility to Sugar-Induced Metabolic Derangements and Impairments of Myocardial Redox Signaling in Mice Chronically Fed with D-Tagatose when Compared to Fructose 136
Dehydroepiandrosterone modulates nuclear factor-kappaB activation in hippocampus of diabetic rats. 135
Local renin–angiotensin system in the kidney of ascitic cirrhosis: An innocent bystander or a major protagonist? 133
In experimental ascitic cirrhosis reduction of adrenergic function by means of α2A adrenergic receptor agonists has considerable aquaretic effects 130
Vitamin D improves insulin sensitivity and myosteatosis in a model of diet-induced insulin resistance 129
High-fructose corn syrup (HFCS) diet induces an NLRP-3 inflammasome-mediated response in the kidney: protection by PPARb/d agonist 126
Miosyn switch in cardiac tissue of diabetic rats: role of oxidative stress. 126
Valproic acid, a histone deacetylase inhibitor, enhances sensitivity to doxorubicin in anaplastic thyroid cancer cells 125
Intrahepatic renin-angiotensin system and liver cirrhosis: an updated reappraisal. 124
Genetic deletion of RAGE in db/db mice interferes in the liver with other AGE-receptors and AGE-detoxifying systems sustaining lipogenesis and inflammation 123
The BET inhibitor JQ1 targets fat metabolism and counteracts obesity 121
Oxidative stress-dependent impairment of cardiac-specific transcription factors in experimental diabetes 121
Liver cirrhosis and intrahepatic rennin-angiotensin system: a reappraisal. 119
Pro-oxidant effect of dehydroepiandrosterone in rats is mediated by PPAR activation. 116
Diabetes and muscle wasting: regulatory effect of dehydroepiandrosterone. 115
In experimental liver cirrhosis impaired secretion of renalase into blood may lead to organ damage and sympathetic overactivity 114
Oxidative and nitrosative stress in brain mitochondria of diabetic rats 113
Totale 23.834
Categoria #
all - tutte 78.080
article - articoli 0
book - libri 0
conference - conferenze 29.732
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 107.812


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.003 0 245 257 327 267 220 298 296 163 133 423 374
2022/20232.827 293 237 94 295 242 655 199 205 342 57 127 81
2023/20241.248 141 201 80 67 96 136 52 108 15 96 108 148
2024/20253.424 35 220 155 294 657 236 137 252 515 221 242 460
2025/20266.959 618 190 359 740 735 352 990 285 548 685 359 1.098
2026/2027767 336 431 0 0 0 0 0 0 0 0 0 0
Totale 27.576